First Horizon Q2 2026 slides: ROTCE hits 15% amid loan growth

First Horizon reported Q2 2026 adjusted EPS of $0.54, beating $0.52 and bringing adjusted PPNR to $364M (+1% QoQ, +8% YoY), but shares fell 3.85% to $24.73 as net interest margin compressed 3 bps to 3.49% on higher deposit costs (+5 bps to 2.33%). Deposits rose to $68.1B (+2% QoQ) supported by a $2B increase in brokered CDs, while asset quality stayed stable (net charge-offs 0.20% of average loans; non-performing loans 0.81%). Management reiterated 2026 guidance for 3–7% revenue growth with approximately flat expenses excluding bonuses/commissions, though it expects deposit costs to rise further in 2H26.

Analysis

The market is punishing the wrong line item if it extrapolates this print mechanically: FHN is still generating enough operating leverage to defend returns, but the stock is signaling that regional-bank valuation remains hostage to deposit beta rather than earnings beats. That matters because funding pressure is not just a margin story; it is a multiple story for the whole KRE complex, especially banks leaning on brokered funding or with weaker fee mix. In the near term, the selloff looks more like de-risking ahead of a potentially tougher Q3/Q4 funding season than a fundamental break.

Second-order, the better relative position is not “best earnings,” but “best balance-sheet elasticity.” Banks with a higher share of insured deposits, stronger noninterest income, or less reliance on hot money should see less NIM compression and more buyback optionality if rates stabilize. FHN’s mix suggests the downside is less about credit and more about whether management can keep repricing pressure from leaking into the funding base; that should help earnings resilience, but not enough to justify a premium rerating until deposit costs clearly plateau.

Contrarian view: consensus may be over-discounting the Q2 margin compression because the market is focusing on the lagging deposit leg while underappreciating fixed-rate asset repricing over the next 2-4 quarters. The real falsifier is a sustained step-up in deposit costs or a sub-3.4% NIM print; if those show up, the current ROTCE level becomes harder to defend and buybacks lose force. If rates fall modestly, the current reaction likely proves too bearish, because the asset-sensitive book should reprice faster than the market is modeling.

Key Decisions for Investors

• Do not chase FHN on the open; wait for confirmation that deposit costs stabilize in the next quarter before adding. If the stock holds above ~$24 and NIM stays near 3.5%, the pullback is likely noise rather than thesis damage.
• Relative-value long FHN / short KRE for 1-3 months only if broader regional-bank weakness resumes on funding-cost fears; target 5-8% spread compression, stop if KRE outperforms on falling-rate expectations.
• Watch-list, not trade: if FHN Q3 deposit costs rise >5 bps sequentially or NIM falls below 3.4%, cut the bullish stance and assume the market is right to compress the multiple.
• For longer-duration exposure, prefer banks with cheaper core funding and more fee income over pure loan growth names; use FHN as a hold-until-proof name, not an aggressive add, given the 2026 funding setup.